Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated

What Diseases and Medications Increase Gallstone Risk?

At a Glance

Gallstone risk can rise with blood disorders that break down red cells, Crohn’s disease, cirrhosis, diabetes, rapid weight loss, and medicines such as ceftriaxone, fibrates, octreotide, lanreotide, and estrogen. Never stop a prescribed medicine without medical advice.

While anyone can develop gallstones, certain underlying medical conditions and specific medications can increase your risk. Having one of these risk factors does not guarantee you will develop gallstones—many people have multiple risk factors or none at all—and finding a stone does not always mean treatment is necessary if you have no symptoms. These factors typically work by changing the chemical makeup of your bile or by preventing your gallbladder from emptying correctly.

Medical Conditions That Increase Risk

  • Hemolytic Anemias (Chronic Red Blood Cell Breakdown): Conditions like sickle cell disease, hereditary spherocytosis, or thalassemia cause red blood cells to break down faster than normal [1]. This chronic breakdown releases high amounts of a yellow waste pigment called bilirubin. The excess bilirubin can clump together to form dark, hard “pigment stones” in the gallbladder [2].
  • Crohn’s Disease and Intestinal Surgery: Crohn’s disease, particularly when it affects the lower small intestine (the terminal ileum) or requires bowel resection surgery, can interfere with how your body reabsorbs bile acids (fluids that help digest fat) [3] [4]. This disruption can promote cholesterol supersaturation, making cholesterol gallstones more likely to form.
  • Advanced Liver Disease (Cirrhosis): Advanced liver scarring, known as cirrhosis, disrupts normal liver function and alters bile production. This significantly increases the odds of developing gallstones, particularly in those with severe cirrhosis or cirrhosis related to hepatitis C [5] [6].
  • Type 2 Diabetes and Insulin Resistance: People with type 2 diabetes have a higher risk of developing gallstones [7]. Research suggests that insulin resistance (when your body doesn’t respond well to insulin) may cause the liver to release more cholesterol into the bile and may also make the gallbladder empty more sluggishly, which can promote bile stasis and stone formation [8].
  • Prolonged Fasting, Rapid Weight Loss, and Intravenous Nutrition: When you dramatically reduce your food intake—whether due to rapid weight loss diets, prolonged fasting, or receiving total parenteral nutrition (TPN, which is intravenous feeding)—your gallbladder is not stimulated to empty regularly [9]. This causes the bile to become stagnant and form sludge or stones [10].
  • Bile Duct Obstructions: Most gallstones form in the gallbladder, but sometimes stones or sludge form directly in the bile ducts. If a bile duct is blocked by a non-stone issue, such as a stricture (a narrowing of the duct) or a tumor, the stagnant bile can become infected or lead to primary duct stone formation [11].

Medications That Can Affect Gallstone Risk

Certain drugs can alter bile composition or affect how well your gallbladder functions. However, you should never stop taking a prescribed medication without first discussing it with your doctor, as the medical benefits of these treatments are important and medication changes must be individualized.

  • Ceftriaxone: This specific intravenous antibiotic can bind with calcium in the bile to form a temporary “sludge” or pseudolithiasis (false stones), especially in children, with higher doses, or during prolonged treatment [12] [13]. While this usually resolves on its own once the medication is finished, it can occasionally cause biliary pain or obstruction.
  • Fibrates: These medications are used to lower triglyceride (fat) levels in the blood. They can sometimes increase the amount of cholesterol secreted into your bile, which may raise the risk of gallstone formation [14] [15].
  • Octreotide and Lanreotide: These drugs (known as somatostatin analogues) are used to treat rare tumors or a growth disorder called acromegaly. Over long periods of use, they can slow down gallbladder emptying [16]. While this can lead to gallstone formation, the risk varies by drug, dose, and duration, and many of the detected stones do not cause symptoms [17].
  • Estrogen Therapy: Exogenous estrogen (estrogen taken from outside the body), such as oral hormone replacement therapy for menopause, can increase cholesterol levels in the bile, which raises the overall risk of developing cholelithiasis (gallstones) [18].

Important Safety Warning: When to Seek Urgent Care

If you have gallstones, it is crucial to know the signs of a blocked or infected bile duct (a condition called cholangitis). Seek emergency medical care immediately if you experience:

  • Fever or chills
  • Severe or persistent pain in your upper right or middle abdomen
  • Jaundice (yellowing of your skin or the whites of your eyes)
  • Dark urine or pale stools
  • Nausea and vomiting
  • Confusion or feeling severely ill

These symptoms can indicate a life-threatening complication that requires urgent assessment, not a routine follow-up appointment [19].

Common questions in this guide

Which health conditions make gallstones more likely?
Risk is higher with blood disorders that cause ongoing red blood cell breakdown, such as sickle cell disease, hereditary spherocytosis, and thalassemia. Crohn’s disease affecting the last part of the small intestine, bowel resection, cirrhosis, type 2 diabetes, and insulin resistance can also contribute.
Which medications can raise my risk of gallstones?
Ceftriaxone can cause temporary bile sludge or false stones, especially with higher doses or longer courses. Fibrates, long-term octreotide or lanreotide, and estrogen therapy can change bile or gallbladder function and may increase stone risk. Do not stop any prescribed medicine without first speaking with your clinician.
Can rapid weight loss or fasting cause gallstones?
Yes. Dramatically reducing food intake, prolonged fasting, rapid weight loss, or receiving total parenteral nutrition can keep the gallbladder from emptying regularly, allowing bile sludge or stones to form. Discuss a safe plan with your healthcare professional if you have these risk factors.
Should I stop a medicine that may be contributing to gallstones?
No—do not stop a prescribed medicine on your own. Contact the clinician who prescribed it so they can weigh its benefits, consider alternatives when appropriate, and decide whether your symptoms or imaging require evaluation.
What gallstone symptoms require emergency care?
Seek emergency care for fever or chills, severe or persistent upper-abdominal pain, yellowing of the skin or eyes, dark urine, pale stools, nausea or vomiting, confusion, or feeling severely ill. These signs may indicate a blocked or infected bile duct and can become life-threatening.
Can gallstones be present without needing treatment?
Yes, finding a gallstone does not always mean treatment is needed if it causes no symptoms. However, symptoms suggesting a blocked or infected bile duct require urgent medical assessment.

Get notified when new evidence is published on cholelithiasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Association between hereditary spherocytosis and gallstone disease: Pathophysiology, diagnosis, and management.

    Cong S, Wang YN, Wang JR, Duan RH

    World journal of gastrointestinal surgery 2025; (17(7)):105033 doi:10.4240/wjgs.v17.i7.105033.

    PMID: 40740904
  2. 2

    Congenital Hemolytic Anemia.

    Haley K

    The Medical clinics of North America 2017; (101(2)):361-374 doi:10.1016/j.mcna.2016.09.008.

    PMID: 28189176
  3. 3

    Risk Factors for Gallstones in Crohn's Disease: A Systematic Review and Meta-Analysis.

    Gong Y, He Y, Wan M, Chen H

    Digestive diseases and sciences 2024; (69(11)):4187-4202 doi:10.1007/s10620-024-08597-1.

    PMID: 39322804
  4. 4

    Lipid and Bile Acid Dysmetabolism in Crohn's Disease.

    Uchiyama K, Kishi H, Komatsu W, et al.

    Journal of immunology research 2018; (2018()):7270486 doi:10.1155/2018/7270486.

    PMID: 30402511
  5. 5

    Hepatitis C Virus Infection Increases Risk of Gallstone Disease in Elderly Chinese Patients with Chronic Liver Disease.

    Li X, Gao P

    Scientific reports 2018; (8(1)):4636 doi:10.1038/s41598-018-22896-4.

    PMID: 29545607
  6. 6

    Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.

    Li X, Wang Z, Wang L, et al.

    Medicine 2017; (96(26)):e7427 doi:10.1097/MD.0000000000007427.

    PMID: 28658178
  7. 7

    The association between diabetes and gallstones: a nationwide population-based cohort study.

    Ratheesh R, Ulrich MT, Ghozy S, et al.

    Przeglad gastroenterologiczny 2023; (18(3)):292-299 doi:10.5114/pg.2023.131395.

    PMID: 37937115
  8. 8

    An update on the pathogenesis of cholesterol gallstone disease.

    Di Ciaula A, Wang DQ, Portincasa P

    Current opinion in gastroenterology 2018; (34(2)):71-80 doi:10.1097/MOG.0000000000000423.

    PMID: 29283909
  9. 9

    Gallstones after bariatric surgery: mechanisms and prophylaxis.

    Chen S, Zheng Y, Cai J, et al.

    Frontiers in surgery 2025; (12()):1506780 doi:10.3389/fsurg.2025.1506780.

    PMID: 40182307
  10. 10

    Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid.

    Çakar S, Eren G, Erdur CB, et al.

    Children (Basel, Switzerland) 2024; (11(12)) doi:10.3390/children11121553.

    PMID: 39767982
  11. 11

    Acute cholangitis: current concepts.

    Lan Cheong Wah D, Christophi C, Muralidharan V

    ANZ journal of surgery 2017; (87(7-8)):554-559 doi:10.1111/ans.13981.

    PMID: 28337833
  12. 12

    Usefulness of Endoscopic Managements in Patients with Ceftriaxone-Induced Pseudolithiasis Causing Biliary Obstruction.

    Doi Y, Takii Y, Ito H, et al.

    Case reports in medicine 2017; (2017()):3835825 doi:10.1155/2017/3835825.

    PMID: 29230246
  13. 13

    Ceftriaxone-induced cholelithiasis in pediatrics: pooled frequency, symptoms, and associated factors - systematic review and meta-analysis.

    Yaseen T, Alam K, Zawiah M, et al.

    Italian journal of pediatrics 2025; (51(1)):284 doi:10.1186/s13052-025-02057-w.

    PMID: 41074174
  14. 14

    PPAR-α agonists are still on the rise: an update on clinical and experimental findings.

    Ferri N, Corsini A, Sirtori C, Ruscica M

    Expert opinion on investigational drugs 2017; (26(5)):593-602 doi:10.1080/13543784.2017.1312339.

    PMID: 28343425
  15. 15

    Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.

    Watanabe S, Nagura K, Okada N, et al.

    Frontiers in pharmacology 2025; (16()):1700589 doi:10.3389/fphar.2025.1700589.

    PMID: 41368577
  16. 16

    Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study.

    Brighi N, Lamberti G, Maggio I, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(5)):689-694 doi:10.1016/j.dld.2018.09.013.

    PMID: 30314949
  17. 17

    Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.

    Aapkes SE, de Haas RJ, Bernts LHP, et al.

    Drugs in R&D 2021; (21(2)):179-188 doi:10.1007/s40268-021-00342-7.

    PMID: 33779943
  18. 18

    Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.

    Wang S, Wang Y, Xu J, Chen Y

    Medicine 2017; (96(14)):e6556 doi:10.1097/MD.0000000000006556.

    PMID: 28383429
  19. 19

    Acute cholangitis - an update.

    Ahmed M

    World journal of gastrointestinal pathophysiology 2018; (9(1)):1-7 doi:10.4291/wjgp.v9.i1.1.

    PMID: 29487761

This page is for informational purposes only and does not constitute medical advice. It explains how illnesses and medications may affect gallstone risk; do not stop a prescribed medicine without discussing it with your clinician, and seek urgent care for severe symptoms.